We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Common Asthma Medicine Cuts Need for COVID-19 Hospitalization
Common Asthma Medicine Cuts Need for COVID-19 Hospitalization
A commonly used asthma medication, AstraZeneca’s Pulmicort (budesonide), was found to significantly reduce COVID-19 symptoms if given within seven days of symptoms appearing, UK researchers reported.